Practical Points for Financial and Tax Due Diligence in Healthcare Organization M&A – Yamada & Partners Tax Corporation

News Summary

Yamada & Partners Tax Corporation explains the practical points of financial and tax due diligence in M&A for medical institutions. They highlight the value of choosing third-party succession as a measure against succession issues, rather than closure or廃業 (haigyo – business closure/liquidation), the importance for chairpersons and directors/principals to start early preparations on a 5-10 year span from around age 60, and the utilization of specialized advisors focused on the healthcare industry as key discussion points.

M&A Medical Editorial Department’s Perspective

The “5-10 year preparation span from around age 60” pointed out by Yamada & Partners Tax Corporation suggests that M&A for medical institutions is not merely a “sale and acquisition” but a strategic process aimed at business continuity and value maximization. Particularly in financial and tax due diligence, it is essential to go beyond simply verifying figures on the books and evaluate less visible values such as future profitability, potential risks, and even contributions to regional healthcare. For example, how will intangible assets like long-standing trust within the community or advanced expertise in specific medical fields be reflected in the acquisition price? Furthermore, the key lies in how expert teams address practical challenges, such as bridging the gap between the transferor’s expected transfer price and the risks discovered by the acquirer during due diligence. This perspective is also what M&A Medical (CentralMedience Inc.) prioritizes most in its proposals to clients.

Discussion Points Indicated by This News

• Precise evaluation of “future potential” and “risks” in financial and tax due diligence determines the success or failure of healthcare organization M&A.
• A long-term preparation period starting around age 60 forms the foundation for resolving succession issues and achieving third-party succession under favorable terms.
• Support from experts who understand the complex regulations and remuneration systems unique to the healthcare industry guarantees the quality of due diligence.
• The significance of third-party succession, which avoids the option of closure or廃業 (haigyo – business closure/liquidation) and aims for the continuation of regional healthcare and the maintenance/improvement of business value, is emphasized.

Practical Questions Arising from This News

• What specific risks are discovered during financial and tax due diligence, and how do they affect the acquisition price?
• When starting preparations around age 60, what specific actions should be taken, and over what timeframe?
• What are the benefits of engaging advisors specialized in the healthcare industry, and how do they differ from general M&A advisors?

If You Feel “Should I Consult Too?”

If a chairperson or director/principal is around 60 years old and facing concerns about lack of successor or business succession, considering M&A as an alternative to closure or廃業 (haigyo – business closure/liquidation) is definitely worthwhile. Especially since the importance of financial and tax due diligence is highlighted, consulting with specialists (healthcare M&A intermediaries, tax accountants, etc.) early on to accurately grasp the value and potential risks of one’s own institution will be the first step towards smooth future succession and business continuity.

M&A Medical (CentralMedience Inc.) supports business succession for medical corporations, hospitals, and clinics as a Small and Medium Enterprise Agency-certified M&A support institution, with a complete success fee system. Consultations are accepted with strict confidentiality. Free consultation here